Jo Waaler received 9 million NOK (~900.000 EUR) for a career fellowship from the South-Eastern Norway Regional Health Authority (HSØ) for the project entitled “Tankyrase Inhibition in Cancer Immunotherapy”.
The primary objective of the project is to investigate Tankyrase inhibition in immune oncology using the proprietary Tankyrase inhibitor OM-153. The study should assist preclinical development of the OM-153 tankyrase inhibitor program.
